Año: 2023
Journal Impact Factor (JIF): 3.70
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
HEMATOLOGY | SCIE | 23/97 | Q1 | T1 | D3 |
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | 54/174 | Q2 | T1 | D4 |
MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 69/189 | Q2 | T2 | D4 |
CELL & TISSUE ENGINEERING | SCIE | 15/31 | Q2 | T2 | D5 |
CELL BIOLOGY | SCIE | 99/205 | Q2 | T2 | D5 |
Año: 2023
Journal Citation Indicator (JCI): 0,810
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 60/174 | Q2 | T2 | D4 | 65,81 |
CELL & TISSUE ENGINEERING | 14/31 | Q2 | T2 | D5 | 56,45 |
CELL BIOLOGY | 80/205 | Q2 | T2 | D4 | 61,22 |
HEMATOLOGY | 30/97 | Q2 | T1 | D4 | 69,59 |
MEDICINE, RESEARCH & EXPERIMENTAL | 67/189 | Q2 | T2 | D4 | 64,82 |
Año:
2023
CiteScore:
6.300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Transplantation | 14/54 | Q1 | T1 | D3 |
Oncology | 116/404 | Q2 | T1 | D3 |
Genetics (clinical) | 35/99 | Q2 | T2 | D4 |
Immunology and Allergy | 91/233 | Q2 | T2 | D4 |
Cancer Research | 96/230 | Q2 | T2 | D5 |
Immunology | 108/236 | Q2 | T2 | D5 |
Cell Biology | 151/285 | Q3 | T2 | D6 |
SJR año:
2023
Factor de Impacto:
1.084
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Transplantation | 10/53 | Q1 | T1 | D2 |
Oncology | 109/397 | Q2 | T1 | D3 |
Genetics (clinical) | 32/99 | Q2 | T1 | D4 |
Immunology and Allergy | 73/225 | Q2 | T1 | D4 |
Cancer Research | 88/233 | Q2 | T2 | D4 |
Cell Biology | 118/295 | Q2 | T2 | D4 |
Immunology | 85/237 | Q2 | T2 | D4 |